osteosarcoma

You have access
Sodium Valproate Enhances Semaphorin 3A-mediated Anti-angiogenesis and Tumor Growth Inhibition in Human Osteosarcoma Cells
TATSUO SAWAI, KOJI YAMANEGI, HIROSHI NISHIURA, HIROYUKI FUTANI and TOSHIYA TACHIBANA

Anticancer Research June 2023, 43 (6) 2539-2550; DOI: https://doi.org/10.21873/anticanres.16421
You have access
Oncolytic Effect of a Recombinant Vesicular Stomatitis Virus Encoding a Tumor-suppressor MicroRNA in an Osteosarcoma Mouse Model
TOMOHIKO SAKUDA, TADAHIKO KUBO, MUHAMMAD PHETRUS JOHAN, TAISUKE FURUTA, TAKEMASA SAKAGUCHI and NOBUO ADACHI

Anticancer Research March 2023, 43 (3) 1185-1191; DOI: https://doi.org/10.21873/anticanres.16264
You have access
Fluoxetine Inhibits STAT3-mediated Survival and Invasion of Osteosarcoma Cells
WEI-TING CHEN, YUAN-HSIN TSAI, PEGGY TAN, FEI-TING HSU, HUI-MIN DAVID WANG, WEI-CHIN LIN, FENG-HUEI LIN and CHING-TE WU

Anticancer Research March 2023, 43 (3) 1193-1199; DOI: https://doi.org/10.21873/anticanres.16265
You have access
Compound Library Screening for Synergistic Drug Combinations: mTOR Inhibitor and Proteasome Inhibitor Effective Against Osteosarcoma Cells
KUNIHIRO ASANUMA, TOMOKI NAKAMURA, KOICHI NAKAMURA, TOMOHITO HAGI, TAKAYUKI OKAMOTO, KOUJI KITA, YUMI MATSUYAMA, KEISUKE YOSHIDA, YUMIKO ASANUMA and AKIHIRO SUDO

Anticancer Research September 2022, 42 (9) 4319-4328; DOI: https://doi.org/10.21873/anticanres.15932
You have access
Magnolol Suppresses ERK/NF-κB Signaling and Triggers Apoptosis Through Extrinsic/Intrinsic Pathways in Osteosarcoma
CHI-HUAN LI, MING-CHOU KU, KUN-CHING LEE, PO-FU YUEH, FEI-TING HSU, RONG-FONG LIN, CHUNG-CHI YANG, WEI-CHUN WANG, JIANN-HWA CHEN, LI-CHO HSU and YUAN-HAO LEE

Anticancer Research September 2022, 42 (9) 4403-4410; DOI: https://doi.org/10.21873/anticanres.15940
You have access
Risk Factors for Hepatic Toxicity of High-dose Methotrexate in Patients With Osteosarcoma
KENTARO ABE, AYAKO MAEDA-MINAMI, TAKU ISHIZU, SHINTARO IWATA, EISUKE KOBAYASHI, TATSUNORI SHIMOI, YOHEI KAWANO, HIRONOBU HASHIMOTO, MASAKAZU YAMAGUCHI, TETSUYA FURUKAWA, SATORU MIYAZAKI and YASUNARI MANO

Anticancer Research February 2022, 42 (2) 1043-1050; DOI: https://doi.org/10.21873/anticanres.15565
You have access
Pretreatment Neutrophil Count and Platelet-lymphocyte Ratio as Predictors of Metastasis in Patients With Osteosarcoma
YOSHIHIRO ARAKI, NORIO YAMAMOTO, KATSUHIRO HAYASHI, AKIHIKO TAKEUCHI, SHINJI MIWA, KENTARO IGARASHI, TAKASHI HIGUCHI, KENSAKU ABE, YUTA TANIGUCHI, HIROTAKA YONEZAWA, SEI MORINAGA, YOHEI ASANO and HIROYUKI TSUCHIYA

Anticancer Research February 2022, 42 (2) 1081-1089; DOI: https://doi.org/10.21873/anticanres.15570
You have access
Oral-recombinant Methioninase Converts an Osteosarcoma from Methotrexate-resistant to -sensitive in a Patient-derived Orthotopic-xenograft (PDOX) Mouse Model
YUSUKE AOKI, YASUNORI TOME, QINGHONG HAN, JUN YAMAMOTO, KAZUYUKI HAMADA, NORIYUKI MASAKI, YUTARO KUBOTA, MICHAEL BOUVET, KOTARO NISHIDA and ROBERT M. HOFFMAN

Anticancer Research February 2022, 42 (2) 731-737; DOI: https://doi.org/10.21873/anticanres.15531
You have access
Osteosarcoma Patient-derived Orthotopic Xenograft (PDOX) Models Used to Identify Novel and Effective Therapeutics: A Review
TAKASHI HIGUCHI, KENTARO IGARASHI, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, MICHAEL BOUVET, HIROYUKI TSUCHIYA and ROBERT M. HOFFMAN

Anticancer Research December 2021, 41 (12) 5865-5871; DOI: https://doi.org/10.21873/anticanres.15406
You have access
The Thioredoxin-1 Inhibitor, PX-12, Suppresses Local Osteosarcoma Progression
HIDEYUKI KINOSHITA, OSAMU SHIMOZATO, TAKESHI ISHII, HIROTO KAMODA, YOKO HAGIWARA, SEIJI OHTORI and TSUKASA YONEMOTO

Anticancer Research December 2021, 41 (12) 6013-6021; DOI: https://doi.org/10.21873/anticanres.15420

Main menu

User menu

Search

osteosarcoma

Pages